Home
About
Our Team
Partners
Solutions
News
Contact
More
Use tab to navigate through the menu items.
info@navaux.com
501-353-0014
News
Hepsin regulates TGFβ signaling via fibronectin proteolysis
ARKANSAS SCIENTISTS DEVELOP BLOOD TEST TO DETECT EARLY STAGE CANCER
NAVAUX PRESENTS PRE-CLINICAL AND CLINICAL CIRCULATING HEPSIN DATA AT THE 2020 AACR ANNUAL MEETING
HEPSIN IN THE DIAGNOSIS OF PROSTATE CANCER
BAPTIST HEALTH AND NAVAUX, INC. OFFER EARLY STAGE CANCER DETECTING BLOOD TEST